摘要
检查急性黄疸型病毒性肝炎、慢性活动性肝炎、肝硬化及肝癌患者血浆 HDL,其所含 Ch 和 Apo-AI 均较正常人低(P<0.01),急性黄疸型病毒性肝炎与慢性活动性肝炎患者 HDL_2及HDL_3中的 Ch、Apo-AI 皆明显降低,但前者 HDL_3-C/HDL_2-C 增高,HDL_2中 Ch/Apo-AI 降低,后者则无上述差异;肝硬化患者仅 HDL_3降低,其中 Ch 为0.41mmol/L,Apo-AI 为4.88mg/L;肝癌患者可见HDL_2降低,其中 Ch 为0.19mmol/L,Apo-AI 为1.17mg/L,HDL_3及 Apo-AI 降低,表明不同肝病具有不同的特征性改变。
HDL in plasma in 22 patients with acute icteric virulent hepatitis(AIVH),10 with chronic active hepatitis(CAH),7 with liver cirrhosis(LC)and 11 with hepatic cellular carcinoma(HCC)were deter- mined.HDL cholesterol(HDL-C)and HDL apoproteinA I(HDL-AI)in all cases were decreased in comparison with the healthy subjects.The Ch.ApoAI in HDL_2 and HDL_3 of patients with AIVH and CAH were decreased significantly.The HDL_3-C/HDL_2-C was increased and ch/ApoAI in HDL_2 was decreased in AIVH.However there was no difference in CAH.Ch and ApoAI in HDL_3 were only de- creased in patients with LC.Contrary to the results of LC,the Ch and ApoAI in HDL_2 were decreased and there was only decreased ApoAI in HDL_3 in HCC. In conclusion there is characteristic varability of HDL subfractions in different liver disease.It is uncertain whether it will provide the diagnosis basis.
基金
国家自然科学基金
关键词
肝疾病
高密度脂蛋白
脱辅基蛋白
MeSH liver diseases/DI
lipoprotien,HDL/AN
apoproteins/AN